Short Summary
Sun Pharma and Nuberg Pharmaceuticals reached a full settlement in their commercial IP dispute before the Delhi High Court. The court formally decreed the suit based on the agreed-upon terms, which included significant concessions from both parties. Furthermore, the judgment mandated that Respondent No. 2 remove a specific trademark entry (No. 3797651) from the Register of Trademarks within six weeks.
Detailed Summary
of the Paris Local Division of the Unified Patent Court concerning a request for extension of time filed by the Bosch defendants. The judge-rapporteur rejected Bosch's request, finding that a non-redacted version of Valeo's 15 June 2026 filing had been deposited in the CMS simultaneously with the redacted version, and that Bosch had failed to exercise due diligence in accessing it. The court ruled that the deadlines under R.29(d) RdP run from 15 June 2026.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Delhi High Court - Orders. Understanding the court's reasoning in Sun Pharma Laboratories Ltd vs Nuberg Pharmaceuticals Pvt. Ltd. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
ASTRAZENCA AB & ANRvsAJANTA PHARMA LTD.
The plaintiffs filed a suit alleging infringement of their patent IN '625. The present order addressed the defendant's request for an early hearing, noting that in connected suits, the court had previously declined interim injunctions.
Saptarishi Herbals LlpvsAsif Enterprises & Anr.
The Delhi High Court issued a comprehensive order in the trademark infringement suit filed by Saptarishi Herbals Llp against Asif Enterprises & Anr. The court allowed several procedural applications, including granting the plaintiff exemptions regarding e-filing advertisements and pre-institution mediation due to the urgent nature of the matter. Furthermore, the plaintiff was granted leave to administer interrogatories upon the defendants, setting a clear path for the commencement of substantive litigation.
Bigtec Private LimitedvsThe Assistant Controller of Patents and Designs
Bigtec Private Limited appealed against the Assistant Controller's order declining the grant of patent for Indian Patent Application No. 314/CHE/2009, concluding that the claims lacked inventive step. The court set aside the impugned order due to non-consideration of appellant's contentions regarding prior art and remanded the matter for re-consideration by a different officer.
Glenmark Pharmaceuticals Ltd.vsMrs. Karlin Pharmaceuticals & Exports Private Limited
The Madras High Court ruled in favor of Glenmark Pharmaceuticals, setting aside the trademark registration of 'CANDEX-B'. The court found that despite the respondent's claim of prior use, there was a clear likelihood of deception or confusion between the appellant's established mark 'CANDID' and 'CANDEX-B', especially given their use in dermatological pharmaceutical products. This decision reinforces the principle that consumer protection against confusion takes precedence over claims of concurrent use when marks are highly similar.
E.R.Squibb & Sons LlcvsUnion of India
International pharmaceutical companies (Petitioners) challenged the recommendations of the Opposition Board regarding their granted patent. They argued that the Board improperly considered a rejoinder filed by the opponent and failed to consider additional evidence submitted by them under Rule 60, due to inaction by the Patent Controller.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.